Functional polymorphism in ABCA1 influences age of symptom onset in coronary artery disease patients

Human Molecular Genetics

Volumn 16, Issue 12, 2007, Pages 1412-1422

  Kyriakou, Theodosios ^a   Pontefract, David E ^a   Viturro, Enrique ^b   Hodgkinson, Conrad P ^a   Laxton, Ross C ^a,e   Bogari, Neda ^a   Cooper, George ^a   Davies, Michael ^a   Giblett, Joel ^a   Day, Ian N M ^a,c   Simpson, Iain A ^c   Albrecht, Christiane ^b,d   Ye, Shu ^a,e  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF BERN   (Switzerland)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; CYTOSINE; GUANOSINE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CHOLESTEROL TRANSPORT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DNA CONTENT; ENZYME ASSAY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; ONSET AGE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN VARIANT; REPORTER GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TANGIER DISEASE;

AGE OF ONSET; AGED; ATP-BINDING CASSETTE TRANSPORTERS; BASE SEQUENCE; CORONARY ARTERIOSCLEROSIS; DISEASE SUSCEPTIBILITY; FEMALE; HAPLOTYPES; HUMANS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS);

EID: 34447322598     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddm091     Document Type: Article

References (44)

1. Oram, J.F. and Heinecke, J.W. (2005) ATP-binding cassette transporter A1: A cell cholesterol exporter that protects against cardiovascular disease. Physiol. Rev., 85, 1343-1372.
2. Cavelier, C., Lorenzi, I., Rohrer, L. and von, E.A. (2006) Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1. Biochim. Biophys. Acta, 1761, 655-666.
3. Lusis, A.J. (2000) Atherosclerosis. Nature, 407, 233-241.
4. Brooks-Wilson, A., Marcil, M., Clee, S.M., Zhang, L.H., Roomp, K., van Dam, M., Yu, L., Brewer, C., Collins, J.A., Molhuizen, H.O. et al. (1999) Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet., 22, 336-345.
5. Bodzioch, M., Orso, E., Klucken, J., Langmann, T., Bottcher, A., Diederich, W., Drobnik, W., Barlage, S., Buchler, C., Porsch-Ozcurumez, M. et al. (1999) The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet., 22 347-351.
6. Rust, S., Rosier, M., Funke, H., Real, J., Amoura, Z., Piette, J.C., Deleuze, J.F., Brewer, H.B., Duverger, N., Denefle, P. and Assmann, G. (1999) Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat. Genet., 22, 352-355.
7. Serfaty-Lacrosniere, C., Civeira, F., Lanzberg, A., Isaia, P., Berg, J., Janus, E.D., Smith, M.P., Jr., Pritchard, P.H., Frohlich, J. and Lees, R.S. (1994) Homozygous Tangier disease and cardiovascular disease. Atherosclerosis, 107, 85-98.
8. Clee, S.M., Kastelein, J.J., van Dam, M., Marcil, M., Roomp, K., Zwarts, K.Y., Collins, J.A., Roelants, R., Tamasawa, N., Stulc, T. et al. (2000) Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes. J. Clin. Invest 106, 1263-1270.
9. van Dam, M.J., de Groot, G.E., Clee, S.M., Hovingh, G.K., Roelants, R., Brooks-Wilson, A., Zwinderman, A.H., Smit, A.J., Smelt, A.H., Groen, A.K. et al. (2002) Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: An observational study. Lancet, 359, 37-42.
10. Wang, J., Burnett, J.R., Near, S., Young, K., Zinman, B., Hanley, A.J., Connelly, P.W., Harris, S.B. and Hegele, R.A. (2000) Common and rare ABCA1 variants affecting plasma HDL cholesterol. Arterioscler. Thromb. Vasc. Biol., 20, 1983-1989.
11. Clee, S.M., Zwinderman, A.H., Engert, J.C., Zwarts, K.Y.,Molhuizen, H.O., Roomp, K., Jukema, J.W., vanWijland, M., van Dam, M., Hudson, T.J. et al. (2001) Common genetic variation in ABCA1 is associated with altered lipoprotein levels and amodified risk for coronary artery disease. Circulation, 103, 1198-1205.
12. Lutucuta, S., Ballantyne, C.M., Elghannam, H., Gotto, A.M., Jr. and Marian, A.J. (2001) Novel polymorphisms in promoter region of ATP binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy. Circ. Res., 88, 969-973.
13. Zwarts, K.Y., Clee, S.M., Zwinderman, A.H., Engert, J.C., Singaraja, R., Loubser, O., James, E., Roomp, K., Hudson, T.J., Jukema, J.W. et al. (2002) ABCA1 regulatory variants influence coronary artery disease independent of effects on plasma lipid levels. Clin. Genet., 61 115-125.
14. Tregouet, D.A., Ricard, S., Nicaud, V., Arnould, I., Soubigou, S., Rosier, M., Duverger, N., Poirier, O., Mace, S., Kee, F. et al. (2004) In-depth haplotype analysis of ABCA1 gene polymorphisms in relation to plasma ApoA1 levels and myocardial infarction. Arterioscler. Thromb. Vasc. Biol., 24, 775-781.
15. Frikke-Schmidt, R., Nordestgaard, B.G., Jensen, G.B. and Tybjaerg-Hansen, A. (2004) Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. J. Clin. Invest, 114, 1343-1353.
16. Kyriakou, T., Hodgkinson, C., Pontefract, D.E., Iyengar, S., Howell, W.M., Wong, Y.K., Eriksson, P. and Ye, S. (2005) Genotypic effect of the -2565C>T polymorphism in the ABCA1 gene promoter on ABCA1 expression and severity of atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 25, 418-423.
17. International HapMap Consortium (2005) A haplotype map of the human genome. Nature, 437, 1299-1320.
18. Nyholt, D.R. (2004) A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am. J. Hum. Genet., 74, 765-769.
19. Ke, X. and Cardon, L.R. (2003) Efficient selective screening of haplotype tag SNPs. Bioinformatics, 19, 287-288.
20. Langmann, T., Porsch-Ozcurumez, M., Heimerl, S., Probst, M., Moehle, C., Taher, M., Borsukova, H., Kielar, D., Kaminski, W.E., ttrich-Wengenroth, E. and Schmitz, G. (2002) Identification of sterol-independent regulatory elements in the human ATP-binding cassette transporter A1 promoter: Role of Sp1/3, E-box binding factors, and an oncostatin M-responsive element. J. Biol. Chem., 277, 14443-14450.
21. Santamarina-Fojo, S., Peterson, K., Knapper, C., Qiu, Y., Freeman, L., Cheng, J.F., Osorio, J., Remaley, A., Yang, X.P., Haudenschild, C. et al. (2000) Complete genomic sequence of the human ABCA1 gene: analysis of the human and mouse ATP-binding cassette A promoter. Proc. Natl Acad. Sci. USA, 97, 7987-7992.
22. Costet, P., Luo, Y., Wang, N. and Tall, A.R. (2000) Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J. Biol. Chem., 275, 28240-28245.
23. Venkateswaran, A., Laffitte, B.A., Joseph, S.B., Mak, P.A., Wilpitz, D.C., Edwards, P.A. and Tontonoz, P. (2000) Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc. Natl Acad. Sci. USA, 97, 12097-12102.
24. Albrecht, C., Baynes, K., Sardini, A., Schepelmann, S., Eden, E.R., Davies, S.W., Higgins, C.F., Feher, M.D., Owen, J.S. and Soutar, A.K. (2004) Two novel missense mutations in ABCA1 result in altered trafficking and cause severe autosomal recessive HDL deficiency. Biochim. Biophys. Acta, 1689, 47-57.
25. Cohen, J.C., Kiss, R.S., Pertsemlidis, A., Marcel, Y.L., McPherson, R. and Hobbs, H.H. (2004) Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science, 305, 869-872.
26. Harada, T., Imai, Y., Nojiri, T., Morita, H., Hayashi, D., Maemura, K., Fukino, K., Kawanami, D., Nishimura, G., Tsushima, K. et al. (2003) A common Ile 823 Met variant of ATP-binding cassette transporter A1 gene (ABCA1) alters high density lipoprotein cholesterol level in Japanese population. Atherosclerosis, 169, 105-112.
27. Glomset, J.A. (1968) The plasma lecithins:cHolesterol acyltransferase reaction. J. Lipid Res., 9, 155-167.
28. Cuchel, M. and Rader, D.J. (2006) Macrophage reverse cholesterol transport: Key to the regression of atherosclerosis? Circulation, 113, 2548-2555.
29. Basso, F., Freeman, L., Knapper, C.L., Remaley, A., Stonik, J., Neufeld, E.B., Tansey, T., Amar, M.J., Fruchart-Najib, J., Duverger, N. et al. (2003) Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations. J. Lipid Res., 44, 296-302.
30. Wellington, C.L., Brunham, L.R., Zhou, S., Singaraja, R.R., Visscher, H., Gelfer, A., Ross, C., James, E., Liu, G., Huber, M.T. et al. (2003) Alterations of plasma lipids in mice via adenoviral-mediated hepatic overexpression of human ABCA1. J. Lipid Res., 44, 1470-1480.
31. Timmins, J.M., Lee, J.Y., Boudyguina, E., Kluckman, K.D., Brunham, L.R., Mulya, A., Gebre, A.K., Coutinho, J.M., Colvin, P.L., Smith, T.L. et al. (2005) Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. J. Clin. Invest, 115, 1333-1342.
32. Ragozin, S., Niemeier, A., Laatsch, A., Loeffler, B., Merkel, M., Beisiegel, U. and Heeren, J. (2005) Knockdown of hepatic ABCA1 by RNA interference decreases plasma HDL cholesterol levels and influences postprandial lipemia in mice. Arterioscler. Thromb. Vasc. Biol., 25, 1433-1438.
33. Haghpassand, M., Bourassa, P.A., Francone, O.L. and Aiello, R.J. (2001) Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. J. Clin. Invest, 108, 1315-1320.
34. Singaraja, R.R., Fievet, C., Castro, G., James, E.R., Hennuyer, N., Clee, S.M., Bissada, N., Choy, J.C., Fruchart, J.C., McManus, B.M. et al. (2002) Increased ABCA1 activity protects against atherosclerosis. J. Clin. Invest, 110, 35-42.
35. Chen, H., Wilkins, L.M., Aziz, N., Cannings, C., Wyllie, D.H., Bingle, C., Rogus, J., Beck, J.D., Offenbacher, S., Cork, M.J. et al. (2006) Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum.Mol. Genet. 15, 519-529.
36. Terry, C.F., Loukaci, V. and Green, F.R. (2000) Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J. Biol. Chem., 275, 18138-18144.
37. Frisdal, E., Klerkx, A.H., Le, G.W., Tanck, M.W., Lagarde, J.P., Jukema, J.W., Kastelein, J.J., Chapman, M.J. and Guerin, M. (2005) Functional interaction between -2629C/A, -2971G/A and -21337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study. Hum. Mol. Genet., 14, 2607-2618.
38. Ye, S., Dunleavey, L., Bannister, W., Day, L.B., Tapper, W., Collins, A.R., Day, I.N. and Simpson, I. (2003) Independent effects of the -2219 G>T and varepsilon 2/varepsilon 3/varepsilon 4 polymorphisms in the apolipoprotein E gene on coronary artery disease: The Southampton Atherosclerosis Study. Eur. J. Hum. Genet., 11, 437-443.
39. Scott, S.P., Teh, A., Peng, C. and Lavin, M.F. (2002) One-step site-directed mutagenesis of ATM cDNA in large (20 kb) plasmid constructs. Hum. Mutat., 20, 323.
40. Gelissen, I.C., Harris, M., Rye, K.A., Quinn, C., Brown, A.J., Kockx, M., Cartland, S., Packianathan, M., Kritharides, L. and Jessup, W. (2006) ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I. Arterioscler. Thromb. Vasc. Biol., 26, 534-540.
41. Tregouet, D.A., Escolano, S., Tiret, L., Mallet, A. and Golmard, J.L. (2004) A new algorithm for haplotype-based association analysis: The Stochastic-EM algorithm. Ann. Hum. Genet., 68, 165-177.
42. Stephens, M., Smith, N.J. and Donnelly, P. (2001) A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet., 68, 978-989.
43. Stephens, M. and Donnelly, P. (2003) A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am. J. Hum. Genet., 73, 1162-1169.
44. Chapman, J.M., Cooper, J.D., Todd, J.A. and Clayton, D.G. (2003) Detecting disease associations due to linkage disequilibrium using haplotype tags: A class of tests and the determinants of statistical power. Hum. Hered., 56, 18-31.